179 related articles for article (PubMed ID: 3060043)
21. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
22. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
23. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
Matsuzawa A; Kaneko T; Ikeda Y
Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
[TBL] [Abstract][Full Text] [Related]
24. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
Schally AV; Redding TW; Comaru-Schally AM
Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
[TBL] [Abstract][Full Text] [Related]
25. [Effect of hydroxy tamoxifens against human breast carcinomas transplanted into nude mice].
Fukutomi T; Ikeda T; Nishiumi T; Kikuyama S; Isobe Y; Nakamura A; Shimada M; Inada T; Ishii S; Koh J
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):50-9. PubMed ID: 3701165
[No Abstract] [Full Text] [Related]
26. [In vitro hormone tests in human breast cancers and their relevance for therapy of metastasizing breast cancer].
Schönfelder M
Zentralbl Chir; 1987; 112(18):1150-4. PubMed ID: 3687263
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
Dehmel A; Becker M; Lemm M; Fichtner I
Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
[TBL] [Abstract][Full Text] [Related]
28. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
Kubota T; Josui K; Fukutomi T; Kitajima M
Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
[TBL] [Abstract][Full Text] [Related]
29. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
Scheiber C; Kiss R; De Launoit Y; Frühling J
Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.
Lee JC; Kim DC; Gee MS; Saunders HM; Sehgal CM; Feldman MD; Ross SR; Lee WM
Cancer Res; 2002 Feb; 62(3):747-55. PubMed ID: 11830529
[TBL] [Abstract][Full Text] [Related]
31. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].
Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y
Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321
[TBL] [Abstract][Full Text] [Related]
33. A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma.
Brooks SC; Horwitz JP; Odden D; Corbett T
Cancer Res; 1987 Sep; 47(17):4623-9. PubMed ID: 3040228
[TBL] [Abstract][Full Text] [Related]
34. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm.
Kiss R; Paridaens RJ; Heuson JC; Danguy AJ
J Natl Cancer Inst; 1986 Jul; 77(1):173-8. PubMed ID: 3459912
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Mizuno Y; Yamamoto T
Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
37. [Hormonal dependency of experimental mammary tumors induced by an estro-progestational combination].
Hannouche N; Samperez S; Rivière MR; Jouan P
C R Seances Soc Biol Fil; 1981; 175(6):744-8. PubMed ID: 6459817
[TBL] [Abstract][Full Text] [Related]
38. Autoradiographic evidence of a loss of iodination within hormone-dependent GR mouse mammary tumors as they progress to independence.
Strum JM
Anat Rec; 1982 Dec; 204(4):323-32. PubMed ID: 7181137
[TBL] [Abstract][Full Text] [Related]
39. [Experimental chemotherapy of human breast carcinomas transplanted into nude mice].
Koh J; Asanuma F; Kurihara H; Konno H; Kubouchi K; Ikeda T; Enomoto K; Ishibiki K; Abe O; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1488-95. PubMed ID: 6440935
[No Abstract] [Full Text] [Related]
40. The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.
von Angerer E; Prekajac J; Berger M
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):531-7. PubMed ID: 3924626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
